Australia · Delayed Price · Currency is AUD PolyNovo Company Description
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.
The company offers NovoSorb Biodegradable Temporising Matrix, a dermal scaffold for the regeneration of the dermis when lost through extensive surgery, trauma, or burn.
It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products.
The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014.
PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
| Country | Australia |
| Founded | 1998 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 254 |
| CEO | Robyn Elliott |
Contact Details
Address: 320 Lorimer Street Port Melbourne, 3207 Australia | |
| Phone | 61 3 8681 4050 |
| Website | polynovo.com |
Stock Details
| Ticker Symbol | PNV |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000PNV0 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Dr. Robyn Elliott B.Sc., BSc (Hons), Ph.D. | Acting Chief Executive Officer and Independent Non-Executive Director |
| Jan-Marcel Gielen C.A. | Chief Financial Officer |
| Dr. David McQuillan Ph.D. | Chief Technical and Scientific Officer |
| Philip Scorgie | Chief Information Officer |
| Kimberley Axon | Chief People Officer |
| Edward Graubart | President of North America |
| Ahmed Hassan | Chief Manufacturing and Supply Chain Officer |
| Dr. Joseph F. Amaral M.D. | Chief Medical Officer |
| David N. Morris BAppSc, BBus | President of Asia Pacific |